Trade Mark Journal No.2026/015 10 April 2026

WO0000001910024 (5)

Office of origin: Denmark

Date of International Registration:26 February 2026
Date of designation in the UK: 26 February 2026
Image for mark 1910024 Kayshild

International priority date claimed: 6 February 2026 (Denmark)
Class 5
Pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for weight reduction and long term weight loss maintenance; pharmaceutical preparations for the treatment of liver diseases; pharmaceutical preparations for the treatment of cardiovascular diseases, chronic kidney disease, heart failure and hypertension; pharmaceutical preparations for the treatment of neurodegenerative disorders and diseases.

Novo Nordisk A/S